Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Obamacare: The Politics of Health Care Reform Entering the Endgame

This article was originally published in RPM Report

Executive Summary

There are multiple political strategies playing out in Washington on health care reform that will directly impact the biopharma industry. In the end biopharma will trade margins for volume. The RPM Report makes predictions on what will make it into the final health reform bill.

You may also be interested in...



Quality Leadership: The Challenge and Opportunity Facing CMS Nominee Berwick

Institute for Healthcare Improvement CEO Don Berwick is the pick to run CMS during the health care reform implementation period. If confirmed, he will have a golden opportunity to try out quality improvement ideas on a national stage.

Health Reform in the Balance: What It Means for Biopharma

The long road to enacting health reform appeared to be close to an end with final negotiations taking place in the White House. But the Senate race for Ted Kennedy's open seat in Massachusetts has put the bill, and pharma's hard-fought concessions, in the breach.

Bending The Cost Curve: Harvard's Cutler Says Rx Can Play A Big Role

Health care cost trends may not be so bad after all, former Obama advisor writes in New England Journal of Medicine. Prescription drugs can help, he writes-but not entirely in the way industry would hope.

Related Content

Topics

UsernamePublicRestriction

Register

PS080583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel